in Health care
Zydus Lifesciences bags USFDA approval for Carbidopa and Levodopa Tablets to treat Parkinson’s disease symptoms
Ahmedabad: Zydus Lifesciences Limited today announced that the company has received final approval from the United States Food and Drug Administration (USFDA) to manufacture and market Carbidopa and Levodopa Tablets USP, 10 mg/100 mg, 25 mg/100 mg, and 25 mg/250 mg (USRLD: Sinemet Tablets, 10 mg/100 mg, 25 mg/100 mg, and 25 mg/250 mg). Carbidopa […] More
